Astrogenetix To Conduct MRSA Research On Shuttle Mission | Aero-News Network
Aero-News Network
RSS icon RSS feed
podcast icon MP3 podcast
Subscribe Aero-News e-mail Newsletter Subscribe

Airborne Unlimited -- Most Recent Daily Episodes

Episode Date

Airborne-Monday

Airborne-Tuesday

Airborne-Wednesday Airborne-Thursday

Airborne-Friday

Airborne On YouTube

Airborne-Unlimited-04.29.24

Airborne-NextGen-04.30.24

Airborne-Unlimited-05.01.24 Airborne-AffordableFlyers--05.02.24

Airborne-Unlimited-05.03.24

Sat, Mar 14, 2009

Astrogenetix To Conduct MRSA Research On Shuttle Mission

Company Developing Potential Therapeutics Using Microgravity

When space shuttle Discovery finally lifts off from the pad on its STS-119 mission, it will be carrying some nasty bacteria... that scientists hope will help earthbound doctors fight virulent infections.

Astrogenetix announced Wednesday it will conduct a microgravity-based virulence survey study aboard Discovery, utilizing methicillin-resistant Staphylococcus aureus (MRSA), Listeria monocytogenes, Enterococcus faecalis and Candida albicans. The research will utilize the unique environment of microgravity, which is known to impact infection potential of microbes, to help discover potential targets for a vaccine or therapeutic agent to fight infections caused by those microbes.

"Discovery of therapeutic targets for MRSA and the other microbes on this survey flight represents the continued growth of our efforts to use microgravity to develop novel pharmaceutical agents," said Thomas B. Pickens III, Chairman of Astrogenetix. "The microgravity environment and its unique characteristics enable us to save lives on Earth by developing products in space."

The work on MSRA builds on the company's previous space-based research focusing on Salmonella, which resulted in the discovery of a vaccine target for that pathogen. MRSA is a type of bacteria that causes "staph" infections that are resistant to treatment with usual antibiotics. According to the Center for Disease Control, it is estimated that MRSA is responsible for more than 94,000 serious infections and 19,000 deaths annually.

"Through expertise gained by sending more than 1,500 science experiments into space, we are positioned to commercialize products derived from microgravity discoveries," added John Porter, Chief Executive Officer of Astrogenetix. "As ISS nears completion we are excited about the opportunity to utilize the ISS National Lab to develop a platform for drug discovery."

The 2005 NASA Authorization Act designated a portion of the ISS as a National Laboratory, and NASA has provided an opportunity for non-governmental entities to conduct research and development and potentially industrial processing on board the ISS. Astrogenetix is one of the first commercial entities to hold a Space Act Agreement with NASA for use of the ISS National Lab.

"The science that Astrogenetix has been conducting for almost two years demonstrates the value of microgravity and NASA is very supportive of their progress," said Mark Uhran, NASA Assistant Associate Administrator for the ISS. "This is the first of many high value products that we believe can be produced on the ISS and we encourage Astrogenetix to continue their pursuit of vaccines and therapeutics that are discovered in space for the benefit of human health on Earth."

FMI: www.astrogenetix.com, www.nasa.gov

Advertisement

More News

ANN's Daily Aero-Term (05.01.24): Say Altitude

Say Altitude Used by ATC to ascertain an aircraft's specific altitude/flight level. When the aircraft is climbing or descending, the pilot should state the indicated altitude round>[...]

ANN's Daily Aero-Linx (05.01.24)

Aero Linx: European Air Law Association (EALA) EALA was established in 1988 with the aim to promote the study of European air law and to provide an open forum for those with an int>[...]

Classic Aero-TV: Korean War Hero Twice Reborn

From 2023 (YouTube Version): The Life, Death, Life, Death, and Life of a Glorious Warbird In 1981, business-owner Jim Tobul and his father purchased a Chance-Vought F4U Corsair. Mo>[...]

Airborne 04.29.24: EAA B-25 Rides, Textron 2024, G700 Deliveries

Also: USCG Retires MH-65 Dolphins, Irish Aviation Authority, NATCA Warns FAA, Diamond DA42 AD This summer, history enthusiasts will have a unique opportunity to experience World Wa>[...]

Airborne Affordable Flyers 05.02.24: Bobby Bailey, SPRG Report Cards, Skydive!

Also: WACO Kitchen Bails, French SportPlane Mfr to FL, Dynon-Advance Flight Systems, Innovation Preview Bobby Bailey, a bit of a fixture in sport aviation circles for his work with>[...]

blog comments powered by Disqus



Advertisement

Advertisement

Podcasts

Advertisement

© 2007 - 2024 Web Development & Design by Pauli Systems, LC